Clinical Trials Directory

Trials / Completed

CompletedNCT04821557

Effect of Microbial Protease Supplementation on Postprandial Amino Acid Levels

Effect of Microbial Protease Supplementation on Postprandial Amino Acid Levels in Healthy Adults

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
University of Illinois at Urbana-Champaign · Academic / Other
Sex
All
Age
20 Years – 50 Years
Healthy volunteers
Accepted

Summary

Dietary protein is digested in the stomach and intestines to smaller peptides and 20 individual amino acids which, when absorbed by the gut into circulation and taken up by skeletal muscle, help stimulate muscle protein synthesis (MPS). Amino acids also provide the building blocks for muscle proteins that contribute to lean mass gains and increased strength following resistance exercise. Therefore, strategies to efficiently maximize amino acid exposure without overconsumption are warranted. Oral enzyme supplementation is a candidate approach to optimize amino acid absorption from dietary protein and protein supplements. Microbial proteases, approved for dietary supplement use, can theoretically speed up the conversion of protein and peptides to amino acids. Protease supplements have been marketed to promote muscle strength by optimizing amino acid absorption, however the clinical evidence is limited. This work will support that ingestion of protease supplements with a meal can allow individuals to more efficiently increase amino acid levels from a given amount of dietary protein.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProtease + ProteinParticipant will consume a microbial protease supplement (31,875 Hemoglobin Unit Tyrosine base (HUT); protease activity) combined with a pea protein beverage (25 g pea protein; Roquette Nutralys® S85F)
DIETARY_SUPPLEMENTPlacebo + ProteinParticipant will consume a placebo supplement (250 mg maltodextrin) combined with a pea protein beverage (25 g pea protein; Roquette Nutralys® S85F)

Timeline

Start date
2021-03-30
Primary completion
2021-09-03
Completion
2021-09-03
First posted
2021-03-29
Last updated
2024-07-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04821557. Inclusion in this directory is not an endorsement.